FDA Says Merck COVID Pill Effective, Experts To Review Safety

Merck's antiviral pill is effective against the current virus, reducing hospitalization or death risk by 30% among adults with mild or moderate disease. However, the effectiveness is less than previously estimated. The company seeks expert opinions on potential risks for pregnant women, including birth defects. In trials, 9 deaths occurred in the placebo group, while only one death was reported among those taking the pill.

What is the primary concern Merck has about its drug?

• It may cause birth defects.

• It is not effective against the virus.

• It is too expensive.

• It has no side effects.

By what percentage does Merck's pill reduce the risk of hospitalization or death?

• 50%

• 10%

• 30%

• 70%

How does the latest effectiveness estimate compare to previous estimates?

• It is higher.

• It is the same.

• It is lower.

• It is not mentioned.

How many deaths were reported in the placebo group?

• 5

• 9

• 0

• 1

How many deaths occurred among those who received the pill?

• 1

• 0

• 5

• 9